30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Curis Inc (CRIS)

Track

In the last 90 days, there has been one insider buy transaction totaling $5,487. This represents a net buy of 10,000 shares. Prior to this, significant selling activity was observed, particularly in early 2022 and 2021, with the CEO making multiple sales. The stock has experienced a significant price decline over the last 90 days.
Stock chart
Ticker: CRIS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
KAITIN KENNETH I
1 purchase — total 5,487 USD
Buy 31 Mar 2026
Value US$628,079.91 | Price 96.78 | Shares 19,804
Planned sale 31 Jan 2022
Value US$3,894,184.11 | Price 241.08 | Shares 7,694
Sale 27 Jan 2022
Value US$7,651.08 | Price 3.18 | Shares 2,406
Planned sale 26 Jan 2021
Value US$32,758.03 | Price 10.59 | Shares 3,094
Sale 25 Jan 2021
Value US$25,021.68 | Price 10.96 | Shares 2,283
Planned sale 24 Jan 2020
Value US$5,076.33 | Price 1.64 | Shares 3,094
Sale 23 Jan 2020
Value US$6,181.65 | Price 1.69 | Shares 3,658
Planned sale 24 Jan 2019
Value US$3,576.97 | Price 1.16 | Shares 3,094
Planned sale 23 Jan 2019
Value US$2,612.73 | Price 1.09 | Shares 2,397
Planned sale 23 Jan 2019
Value US$19,474.95 | Price 1.05 | Shares 18,500
Planned sale 23 Jan 2019
Value US$5,900.40 | Price 1.07 | Shares 5,500
Planned sale 23 Jan 2019
Value US$15,587.36 | Price 1.05 | Shares 14,800
Planned sale 23 Jan 2019
Value US$15,581.44 | Price 1.05 | Shares 14,800
Planned sale 23 Jan 2019
Value US$19,476.80 | Price 1.05 | Shares 18,500
Buy 16 Nov 2017
Value US$24,500.00 | Price 0.98 | Shares 25,000
Buy 15 Nov 2017
Value US$53,000.00 | Price 1.06 | Shares 50,000
Planned sale 5 May 2017
Value US$30,721.46 | Price 1.90 | Shares 16,176
Planned sale 4 May 2017
Value US$59,158.54 | Price 1.97 | Shares 30,100
Planned sale 3 May 2017
Value US$65,544.00 | Price 2.18 | Shares 30,000
Planned sale 2 May 2017
Value US$82,313.74 | Price 2.31 | Shares 35,646
Planned sale 1 May 2017
Value US$90,708.94 | Price 2.38 | Shares 38,113
Planned sale 28 Apr 2017
Value US$105,014.60 | Price 2.45 | Shares 42,949
Planned sale 27 Apr 2017
Value US$95,624.02 | Price 2.57 | Shares 37,202
Planned sale 26 Apr 2017
Value US$52,441.71 | Price 2.65 | Shares 19,814
Planned sale 26 Apr 2017
Value US$86,647.66 | Price 2.65 | Shares 32,738
Planned sale 25 Apr 2017
Value US$148,305.92 | Price 2.60 | Shares 56,940
Planned sale 24 Apr 2017
Value US$107,861.83 | Price 2.56 | Shares 42,076
Planned sale 21 Apr 2017
Value US$117,841.20 | Price 2.58 | Shares 45,705
Planned sale 20 Apr 2017
Value US$59,979.35 | Price 2.66 | Shares 22,541
Buy 7 Sep 2016
Value US$24,499,999.20 | Price 2.40 | Shares 10,208,333
Sale 27 May 2016
Value US$16,900.00 | Price 1.69 | Shares 10,000
Sale 27 May 2016
Value US$8,450.00 | Price 1.69 | Shares 5,000
Sale 26 May 2016
Value US$17,600.00 | Price 1.76 | Shares 10,000
Sale 26 May 2016
Value US$8,800.00 | Price 1.76 | Shares 5,000
Planned sale 30 Dec 2015
Value US$43,344.00 | Price 3.01 | Shares 14,400
Planned sale 29 Dec 2015
Value US$32,592.00 | Price 2.91 | Shares 11,200
Planned sale 28 Dec 2015
Value US$31,240.00 | Price 2.84 | Shares 11,000
Planned sale 24 Dec 2015
Value US$7,540.00 | Price 2.90 | Shares 2,600
Planned sale 23 Dec 2015
Value US$31,610.00 | Price 2.90 | Shares 10,900
Planned sale 22 Dec 2015
Value US$104,500.00 | Price 2.75 | Shares 38,000
Planned sale 21 Dec 2015
Value US$287,000.00 | Price 2.87 | Shares 100,000
Planned sale 18 Dec 2015
Value US$576,450.00 | Price 3.05 | Shares 189,000
Buy 27 Aug 2014
Value US$100,624.00 | Price 1.60 | Shares 62,890
Buy 11 Dec 2013
Value US$7,560.00 | Price 2.52 | Shares 3,000
Buy 12 Nov 2013
Value US$28,600.00 | Price 2.86 | Shares 10,000
Buy 8 Nov 2013
Value US$59,000.00 | Price 2.95 | Shares 20,000
Buy 16 Sep 2013
Value US$43,691.00 | Price 4.37 | Shares 10,000
Sale 16 Aug 2013
Value US$200,000.00 | Price 4.00 | Shares 50,000
Buy 16 Aug 2013
Value US$200,000.00 | Price 4.00 | Shares 50,000
Sale 8 May 2013
Value US$321,352.40 | Price 3.70 | Shares 86,852
Sale 7 May 2013
Value US$145,200.00 | Price 3.63 | Shares 40,000
Sale 6 May 2013
Value US$219,600.00 | Price 3.66 | Shares 60,000
Sale 3 May 2013
Value US$242,450.00 | Price 3.73 | Shares 65,000
Sale 2 May 2013
Value US$183,000.00 | Price 3.66 | Shares 50,000
Sale 2 May 2013
Value US$220,200.00 | Price 3.67 | Shares 60,000
Sale 2 May 2013
Value US$64,935.72 | Price 3.66 | Shares 17,742
Sale 2 May 2013
Value US$191,264.28 | Price 3.66 | Shares 52,258
Buy 6 Dec 2012
Value US$75,750.00 | Price 3.03 | Shares 25,000
Sale 19 Sep 2012
Value US$215,500.00 | Price 4.31 | Shares 50,000
Planned sale 18 Sep 2012
Value US$112,350.00 | Price 4.28 | Shares 26,250
Planned sale 1 Aug 2012
Value US$227,520.00 | Price 4.74 | Shares 48,000
Sale 19 Jun 2012
Value US$661,640.00 | Price 4.76 | Shares 139,000
Sale 18 Jun 2012
Value US$712,500.00 | Price 4.75 | Shares 150,000
Sale 15 Jun 2012
Value US$52,030.00 | Price 4.73 | Shares 11,000
Planned sale 1 May 2012
Value US$180,143.86 | Price 4.78 | Shares 37,687
Planned sale 1 May 2012
Value US$174,054.14 | Price 4.78 | Shares 36,413
Planned sale 1 May 2012
Value US$172,800.00 | Price 4.80 | Shares 36,000
Planned sale 30 Apr 2012
Value US$81,206.79 | Price 4.83 | Shares 16,813
Planned sale 30 Apr 2012
Value US$279,352.71 | Price 4.83 | Shares 57,837
Planned sale 19 Apr 2012
Value US$12,129.21 | Price 5.01 | Shares 2,421
Planned sale 18 Apr 2012
Value US$202,519.23 | Price 5.01 | Shares 40,423
Sale 28 Mar 2012
Value US$393,600.00 | Price 4.92 | Shares 80,000
Planned sale 23 Dec 2011
Value US$133,672.50 | Price 4.50 | Shares 29,705
Buy 11 May 2011
Value US$25,024.00 | Price 3.68 | Shares 6,800
Sale 31 Mar 2011
Value US$318,825.00 | Price 3.25 | Shares 98,100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-01 2026-03-31 B Purchase
KAITIN KENNETH I
Non-Executive Director
19,804 +15.2%
96.78
US$628,080 		19,804 +15.2% 96.78 US$628,080
2022-01-31 2022-01-31 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
7,694 +19.5%
241.08
US$3,894,184 		7,694 +19.5% 241.08 US$3,894,184
2022-01-31 2022-01-27 S Sale
3.5
Dentzer James E

President & CEO

Executive Director
76,558 -48.4%
430.09
US$3,139,785 		76,558 -48.4% 430.09 US$3,139,785
2021-01-26 2021-01-26 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
3,094 -4.4%
10.59
US$32,758 		3,094 -4.4% 10.59 US$32,758
2021-01-26 2021-01-25 S Sale
3.5
Dentzer James E

President & CEO

Executive Director
2,283 -3.1%
10.96
US$25,022 		2,283 -3.1% 10.96 US$25,022
2020-01-24 2020-01-24 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
3,094 -6.8%
1.64
US$5,076 		3,094 -6.8% 1.64 US$5,076
2020-01-24 2020-01-23 S Sale
3.5
Dentzer James E

President & CEO

Executive Director
3,658 -7.5%
1.69
US$6,182 		3,658 -7.5% 1.69 US$6,182
2019-01-25 2019-01-24 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
3,094 -6.9%
1.16
US$3,577 		3,094 -6.9% 1.16 US$3,577
2019-01-25 2019-01-23 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
2,397 -5.1%
1.09
US$2,613 		2,397 -5.1% 1.09 US$2,613
2019-01-25 2019-01-23 PlS Planned sale
GREENACRE MARTYN D
Non-Executive Director
18,500 -41.5%
1.05
US$19,475 		18,500 -41.5% 1.05 US$19,475
2019-01-25 2019-01-23 PlS Planned sale
Martell Robert

Head of Research & Development

Officer
5,500 -19.3%
1.07
US$5,900 		5,500 -19.3% 1.07 US$5,900
2019-01-25 2019-01-23 PlS Planned sale
KAITIN KENNETH I
Non-Executive Director
14,800 -34.5%
1.05
US$15,587 		14,800 -34.5% 1.05 US$15,587
2019-01-25 2019-01-23 PlS Planned sale
Kunkel Lori Anne
Non-Executive Director
14,800 -40.0%
1.05
US$15,581 		14,800 -40.0% 1.05 US$15,581
2019-01-25 2019-01-23 PlS Planned sale
Rubin Marc
Non-Executive Director
18,500 -39.1%
1.05
US$19,477 		18,500 -39.1% 1.05 US$19,477
2017-11-16 2017-11-16 B Purchase Rubin Marc
25,000 +94.0%
0.98
US$24,500 		25,000 +94.0% 0.98 US$24,500
2017-11-15 2017-11-15 B Purchase Fattaey Ali Ph.D.

President & CEO

Executive Director
50,000 +75.9%
1.06
US$53,000 		50,000 +75.9% 1.06 US$53,000
2017-05-05 2017-05-05 PlS Planned sale MCNAB JAMES R Non-Executive Director
16,176 -24.4%
1.90
US$30,721 		16,176 -24.4% 1.90 US$30,721
2017-05-05 2017-05-04 PlS Planned sale MCNAB JAMES R Non-Executive Director
30,100 -31.3%
1.97
US$59,159 		30,100 -31.3% 1.97 US$59,159
2017-05-05 2017-05-03 PlS Planned sale MCNAB JAMES R Non-Executive Director
30,000 -23.8%
2.18
US$65,544 		30,000 -23.8% 2.18 US$65,544
2017-05-02 2017-05-02 PlS Planned sale MCNAB JAMES R Non-Executive Director
35,646 -22.0%
2.31
US$82,314 		35,646 -22.0% 2.31 US$82,314
2017-05-02 2017-05-01 PlS Planned sale MCNAB JAMES R Non-Executive Director
38,113 -19.1%
2.38
US$90,709 		38,113 -19.1% 2.38 US$90,709
2017-05-02 2017-04-28 PlS Planned sale MCNAB JAMES R Non-Executive Director
42,949 -17.7%
2.45
US$105,015 		42,949 -17.7% 2.45 US$105,015
2017-04-27 2017-04-27 PlS Planned sale MCNAB JAMES R
37,202 -13.3%
2.57
US$95,624 		37,202 -13.3% 2.57 US$95,624
2017-04-27 2017-04-26 PlS Planned sale MCNAB JAMES R
19,814 -6.6%
2.65
US$52,442 		19,814 -6.6% 2.65 US$52,442
2017-04-27 2017-04-26 PlS Planned sale MCNAB JAMES R
32,738 -3.6%
2.65
US$86,648 		32,738 -3.6% 2.65 US$86,648
2017-04-27 2017-04-25 PlS Planned sale MCNAB JAMES R
56,940 -5.9%
2.60
US$148,306 		56,940 -5.9% 2.60 US$148,306
2017-04-24 2017-04-24 PlS Planned sale MCNAB JAMES R
42,076 -3.2%
2.56
US$107,862 		42,076 -3.2% 2.56 US$107,862
2017-04-24 2017-04-21 PlS Planned sale MCNAB JAMES R
45,705 -3.4%
2.58
US$117,841 		45,705 -3.4% 2.58 US$117,841
2017-04-24 2017-04-20 PlS Planned sale MCNAB JAMES R
22,541 -1.6%
2.66
US$59,979 		22,541 -1.6% 2.66 US$59,979
2016-09-09 2016-09-07 B Purchase Aurigene Discovery Technologies Ltd Large shareholder
10,208,333 +59.6%
2.40
US$24,499,999 		10,208,333 +59.6% 2.40 US$24,499,999
2016-05-27 2016-05-27 S Sale GREENACRE MARTYN D Non-Executive Director
10,000 -22.1%
1.69
US$16,900 		10,000 -22.1% 1.69 US$16,900
2016-05-27 2016-05-27 S Sale GREENACRE MARTYN D Non-Executive Director
5,000 -12.4%
1.69
US$8,450 		5,000 -12.4% 1.69 US$8,450
2016-05-27 2016-05-26 S Sale KAITIN KENNETH I Non-Executive Director
10,000 -27.2%
1.76
US$17,600 		10,000 -27.2% 1.76 US$17,600
2016-05-27 2016-05-26 S Sale KAITIN KENNETH I Non-Executive Director
5,000 -15.7%
1.76
US$8,800 		5,000 -15.7% 1.76 US$8,800
2015-12-30 2015-12-30 PlS Planned sale PASSERI DANIEL R Non-Executive Director
14,400 -6.8%
3.01
US$43,344 		14,400 -6.8% 3.01 US$43,344
2015-12-30 2015-12-29 PlS Planned sale PASSERI DANIEL R Non-Executive Director
11,200 -5.3%
2.91
US$32,592 		11,200 -5.3% 2.91 US$32,592
2015-12-29 2015-12-28 PlS Planned sale PASSERI DANIEL R Non-Executive Director
11,000 -5.2%
2.84
US$31,240 		11,000 -5.2% 2.84 US$31,240
2015-12-29 2015-12-24 PlS Planned sale PASSERI DANIEL R Non-Executive Director
2,600 -1.3%
2.90
US$7,540 		2,600 -1.3% 2.90 US$7,540
2015-12-23 2015-12-23 PlS Planned sale PASSERI DANIEL R Non-Executive Director
10,900 -5.2%
2.90
US$31,610 		10,900 -5.2% 2.90 US$31,610
2015-12-23 2015-12-22 PlS Planned sale PASSERI DANIEL R Non-Executive Director
38,000 -16.0%
2.75
US$104,500 		38,000 -16.0% 2.75 US$104,500
2015-12-21 2015-12-21 PlS Planned sale PASSERI DANIEL R Non-Executive Director
100,000 -33.5%
2.87
US$287,000 		100,000 -33.5% 2.87 US$287,000
2015-12-21 2015-12-18 PlS Planned sale PASSERI DANIEL R Non-Executive Director
189,000 -48.7%
3.05
US$576,450 		189,000 -48.7% 3.05 US$576,450
2014-08-28 2014-08-27 B Purchase Fattaey Ali Ph.D.

President & CEO

Executive Director
62,890 +2096.3%
1.60
US$100,624 		62,890 +2096.3% 1.60 US$100,624
2013-12-12 2013-12-11 B Purchase Fattaey Ali Ph.D.

President & COO

Officer
3,000 +inf%
2.52
US$7,560 		3,000 +inf% 2.52 US$7,560
2013-11-12 2013-11-12 B Purchase GRAY MICHAEL

CFO

Officer
10,000 +10.3%
2.86
US$28,600 		10,000 +10.3% 2.86 US$28,600
2013-11-08 2013-11-08 B Purchase Pienta Kenneth Non-Executive Director
20,000 +200.0%
2.95
US$59,000 		20,000 +200.0% 2.95 US$59,000
2013-11-08 2013-09-16 B Purchase Pienta Kenneth Non-Executive Director
10,000 +inf%
4.37
US$43,691 		10,000 +inf% 4.37 US$43,691
2013-08-19 2013-08-16 S Sale MCNAB JAMES R Non-Executive Director
50,000 -50.0%
4.00
US$200,000 		50,000 -50.0% 4.00 US$200,000
2013-08-19 2013-08-16 B Purchase MCNAB JAMES R Non-Executive Director
50,000 +25.0%
4.00
US$200,000 		50,000 +25.0% 4.00 US$200,000
2013-05-08 2013-05-08 S Sale PASSERI DANIEL R

CEO and Director

Officer
86,852 -30.4%
3.70
US$321,352 		86,852 -30.4% 3.70 US$321,352
2013-05-08 2013-05-07 S Sale PASSERI DANIEL R

CEO and Director

Officer
40,000 -16.7%
3.63
US$145,200 		40,000 -16.7% 3.63 US$145,200
2013-05-06 2013-05-06 S Sale PASSERI DANIEL R

CEO and Director

Officer
60,000 -21.6%
3.66
US$219,600 		60,000 -21.6% 3.66 US$219,600
2013-05-06 2013-05-03 S Sale PASSERI DANIEL R

CEO and Director

Officer
65,000 -30.1%
3.73
US$242,450 		65,000 -30.1% 3.73 US$242,450
2013-05-06 2013-05-02 S Sale PASSERI DANIEL R

CEO and Director

Officer
50,000 -24.9%
3.66
US$183,000 		50,000 -24.9% 3.66 US$183,000
2013-05-03 2013-05-02 S Sale GREENACRE MARTYN D Non-Executive Director
60,000 -63.1%
3.67
US$220,200 		60,000 -63.1% 3.67 US$220,200
2013-05-03 2013-05-02 S Sale NOEL MARK

VP, Tech Management

Officer
17,742 -39.2%
3.66
US$64,936 		17,742 -39.2% 3.66 US$64,936
2013-05-03 2013-05-02 S Sale NOEL MARK

VP, Tech Management

Officer
52,258 -65.5%
3.66
US$191,264 		52,258 -65.5% 3.66 US$191,264
2012-12-07 2012-12-06 B Purchase PASSERI DANIEL R

CEO and Director

Officer
25,000 +19.9%
3.03
US$75,750 		25,000 +19.9% 3.03 US$75,750
2012-09-21 2012-09-19 S Sale GREENACRE MARTYN D Non-Executive Director
50,000 -58.7%
4.31
US$215,500 		50,000 -58.7% 4.31 US$215,500
2012-09-21 2012-09-18 PlS Planned sale GRAY MICHAEL

COO and CFO

Officer
26,250 -23.3%
4.28
US$112,350 		26,250 -23.3% 4.28 US$112,350
2012-08-03 2012-08-01 PlS Planned sale NOEL MARK

VP, Tech Management

Officer
48,000 -63.5%
4.74
US$227,520 		48,000 -63.5% 4.74 US$227,520
2012-06-19 2012-06-19 S Sale MCNAB JAMES R Non-Executive Director
139,000 -11.4%
4.76
US$661,640 		139,000 -11.4% 4.76 US$661,640
2012-06-19 2012-06-18 S Sale MCNAB JAMES R Non-Executive Director
150,000 -11.0%
4.75
US$712,500 		150,000 -11.0% 4.75 US$712,500
2012-06-19 2012-06-15 S Sale MCNAB JAMES R Non-Executive Director
11,000 -0.8%
4.73
US$52,030 		11,000 -0.8% 4.73 US$52,030
2012-05-02 2012-05-01 PlS Planned sale NOEL MARK

VP, Tech Management

Officer
37,687 -57.8%
4.78
US$180,144 		37,687 -57.8% 4.78 US$180,144
2012-05-02 2012-05-01 PlS Planned sale NOEL MARK

VP, Tech Management

Officer
36,413 -56.9%
4.78
US$174,054 		36,413 -56.9% 4.78 US$174,054
2012-05-02 2012-05-01 PlS Planned sale PASSERI DANIEL R

CEO and Director

Officer
36,000 -22.3%
4.80
US$172,800 		36,000 -22.3% 4.80 US$172,800
2012-05-02 2012-04-30 PlS Planned sale PASSERI DANIEL R

CEO and Director

Officer
16,813 -11.8%
4.83
US$81,207 		16,813 -11.8% 4.83 US$81,207
2012-05-02 2012-04-30 PlS Planned sale PASSERI DANIEL R

CEO and Director

Officer
57,837 -31.5%
4.83
US$279,353 		57,837 -31.5% 4.83 US$279,353
2012-04-20 2012-04-19 PlS Planned sale GRAY MICHAEL

COO and CFO

Officer
2,421 -2.7%
5.01
US$12,129 		2,421 -2.7% 5.01 US$12,129
2012-04-20 2012-04-18 PlS Planned sale GRAY MICHAEL

COO and CFO

Officer
40,423 -31.8%
5.01
US$202,519 		40,423 -31.8% 5.01 US$202,519
2012-03-29 2012-03-28 S Sale GREENACRE MARTYN D Non-Executive Director
80,000 -69.5%
4.92
US$393,600 		80,000 -69.5% 4.92 US$393,600
2011-12-27 2011-12-23 PlS Planned sale BAYH SUSAN B Non-Executive Director
29,705 -54.3%
4.50
US$133,672 		29,705 -54.3% 4.50 US$133,672
2011-05-11 2011-05-11 B Purchase KAITIN KENNETH I Non-Executive Director
6,800 +34.0%
3.68
US$25,024 		6,800 +34.0% 3.68 US$25,024
2011-04-01 2011-03-31 S Sale PASSERI DANIEL R

CEO and Director

Officer
98,100 -60.1%
3.25
US$318,825 		98,100 -60.1% 3.25 US$318,825
Explore more

More insider trading research around Curis Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America